Anlon Healthcare Ltd.
₹14.53
-0.1 (-0.7%)
AHCL Share Price
As on August 19, 2026
SectorNA
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap₹ 766 Cr
P/E Ratio27.08
Dividend YieldN/A
Trendline Performance
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
Company Information
Market Insights
Open14.6
High14.7
NSE SymbolAHCL
Close14.53
Low14.38
BSE Symbol544497
Previous Years High/Low
1 Year High17.27
3 Year High17.27
5 Year High17.27
1 Year Low9.08
3 Year Low9.08
5 Year Low9.08
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 14.47 | Bullish |
| 10-DMA | 14.42 | Bullish |
| 20-DMA | 14.72 | Bearish |
| 50-DMA | 15.21 | Bearish |
| 100-DMA | 14.29 | Bullish |
| 200-DMA | 13.86 | Bullish |
Historical Performance
1 Year
N/A
3 Years
N/A
5 Years
N/A
10 Years
N/A
Shareholding Pattern
%
Values Analysis
Loading chart...
Profit & Loss
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 |
|---|---|---|
| Net Sales | 1,720 | 1,203 |
| Total Expenditure | 1,244 | 881 |
| Other Income | 3 | 2 |
| Operating Profit | 478 | 324 |
| Interest | 37 | 37 |
| Depreciation | 15 | 18 |
| Profit Before Tax | 425 | 269 |
| Consolidated Net Profit | 285 | 205 |
| Adjusted EPS | 1 | 1 |
Compounded Sales Growth
10 Years:7.4
5 Years:7.4
3 Years:7.4
TTM:7.4
Compounded Profit Growth
10 Years:6.8
5 Years:6.8
3 Years:6.8
TTM:6.8
Stock Price CAGR
10 Years:N/A
5 Years:N/A
3 Years:N/A
TTM:N/A
Return on Equity
10 Years:N/A
5 Years:N/A
3 Years:N/A
last year:0.5
Quarterly Results
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 |
|---|---|---|
| Share Capital | 532 | 399 |
| Total Reserves | 1,771 | 406 |
| Long-Term Borrowings | --- | --- |
| Total Non-Current Liabilities | 116 | 408 |
| Other Current Liabilities | 140 | 43 |
| Short Term Borrowings | 376 | 282 |
| Total Liabilities | 3,740 | 1,813 |
| Capital Work in Progress | --- | --- |
| Long Term Loans & Advances | 70 | --- |
| Currents Investments | --- | 9 |
| Short Term Loans and Advances | 856 | 298 |
| Total Current Assets | 3,083 | 1,585 |
| Total Assets | 3,740 | 1,813 |
| Adjusted Book Value | 4 | 2 |
0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
- The stock has a high PE of 27.08, indicating expensive valuation or elevated growth expectations.
- Over the last three years, the stock delivered price CAGR data is unavailable.
- The stock carries a low beta of 0.6, suggesting lower volatility than the broader market.
- In the last financial year, the company reported an EBITDA of ₹478 million, reflecting positive operating performance.
- In the previous financial year, the company generated revenue of ₹1720 million, suggesting a mid-sized operation.
Investment Calculator
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1583996.5
No. of Shares: 109016 (Approx)
Performance:58.4%
583996.5
NIFTY Performance: -3.9%
1 day Top Gainers
Top Performing Stocks from the same sector
Get Your Portfolio Reviewed
Latest News
Stay Updated with Our Market Newsletters
